British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main ...

The Indian pharmaceuticals market continued to report mid-single-digit growth in August, as sales grew 6.3% annually, ...

India’s second nuclear-capable ballistic missile submarine joined its naval fleet late last month, a move the government says strengthens its nuclear deterrent as New Delhi casts a wary eye at ...

Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees) ...

The company promoted by GSK Velu, who was an investor in diagnostic chain Metropolis ... In 2023, M&G also announced that it would invest $75 million in Vivriti India Retail Asset Fund, India’s first ...

Sheetal Sapale, vice-president (commercial) at Pharmarack, said that new introductions and price growth have driven the ...

Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week.

After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has delivered the goods in the all ...

Star India has filed a Statement of Case against Zee Entertainment, seeking $940 million in damages over the terminated ICC ...

WeAce is proud to announce the launch of its Global Digital Coaching and Mentoring Platform at the SPARK Annual Leadership ...

GSK plc (LSE/NYSE: GSK), a leading global pharmaceutical company, has reached a confidential settlement in a Zantac (ranitidine) related prostate cancer lawsuit filed by Mr. Isaac Dixon in ...

GSK Says mRNA Flu Shot Shows Promise in Boost for Pipeline GSK could beat Pfizer to market, says chief commercial officer Several drugmakers are betting on mRNA seasonal flu vaccines ...